Bayer AG ($BAYRY) announced an update on their ongoing clinical study. Bayer AG is running a new observational study in Germany on Talcid ...

Bayer Crop Science’s seed production plants play a critical role in ensuring the performance farmers expect from DEKALB® corn and Asgrow® soybeans. In this Managing for Profit, Clint Rodenberg, ...

The "AI in Agriculture: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for AI in agriculture is estimated to grow from $2.8 billion in 2025 to reach $8.5 ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

The DAX Index had a strong performance in 2025 as it jumped by 22%, which mirrored the growth of other global indices like the S&P 500 and the Dow Jones indices. It was trading at €24,340, up by 32% ...

Bayer has long been known as a leader in seed and trait innovation. In this episode of Managing for Profit, Connie Davis, Product Development Scientist for Bayer Crop Science, talks about how ...

This Small-cap Stock, engaged in manufacturing fertilizers, chemicals, sugar, PVC products, and hybrid seeds, serving farmers and industries across North and Central India, jumped 9.29 percent after ...

Bayer is suing insurance giant AIG, alleging decades-old insurance policies should have helped cover billions of dollars in legal costs from Roundup and PCB cases now being shouldered by the German ...

New study to test Sema3A antibody in rare genetic kidney disease Evotec SE has announced that partner Bayer AG has initiated a phase 2 clinical study of BAY 3401016, a monoclonal antibody targeting ...

The Trump administration has urged the U.S. Supreme Court to hear Bayer's case aimed at stopping thousands of cancer lawsuits over its Roundup weedkiller. Bayer CEO Bill Anderson joined "The Claman ...

LEVERKUSEN, Germany--(BUSINESS WIRE)--Bayer is pleased the Solicitor General supports U. S. Supreme Court review of the petition for a writ of certiorari in the Durnell case and agrees with the ...

Bayer stock jumped on Monday after the German healthcare company said a late-stage stroke drug trial achieved its goals, a development that also helped a rival creating a competing drug. Bayer didn’t ...